Specialty Pharmacy

Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how specialty pharmacy can help patients manage high out of pocket costs for specialty drugs.

Niraparib (Zejula) FDA approved to treat epithelial ovarian, fallopian tube, or primary peritoneal cancers.

There is little room for error in the highly competitive specialty pharmacy landscape.

Findings open the door for new therapeutic options for myelin regeneration in multiple sclerosis.

Most models were cancer-free within 6 weeks of treatment with selenomab-drug conjugates.

New report reveals trends in the 8 major markets over the next decade.

Top news of the day from across the health care landscape.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how biosimilars could impact specialty pharmacy into the immediate future.

Pharmacists can address barriers to treatment, engage with patients, and advocate for change at the community and federal levels.

Top news of the week in oncology and cancer drug development.

Checkpoint inhibitors plus myeloid-derived suppressor cell inhibitors show promise as prostate cancer treatment.

Quiescent stem cells are dormant and are not impacted by cancer treatments.

Top five most popular articles this week on Specialty Pharmacy Times.

Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses the potential impact of value-based care on specialty pharmacy.

The addition of abemaciclib to fulvestrant appeared to effectively improve progression-free survival in patients with breast cancer.

Study suggests Medicare reform to help patients predict monthly medication costs.

Researchers from the VA system examined how mail-order delivery of drugs affects their patients with HIV.

Bavencio (avelumab) is indicated to treat metastatic Merkel cell carcinoma.

New research indicates that high consumption of certain dairy products may either increase or decrease the risk of developing breast cancer, depending on the food.

Monthly and annual spending limits would likely benefit Part D enrollees.

Genentech’s $100,000 grant will fund a home-based telemedicine program.

Policies targeting both physicians and hospitals could reduce wasteful health care spending.

Mapping lung cancer cell interactions can unveil new targeted treatment techniques.

Jonathan Van Lare, PharmD, director of Clincal Services at Pharmacy Advantage, discusses the elements of a successful specialty pharmacy therapy management program.

Vitamin C observed to kill cancer stem-like cells.

Leading cardiologists say it is difficult to get their patients access to evolocumab.

National Association of Specialty Pharmacy commissions white paper that explores how direct and indirect remuneration fees affect the specialty pharmacy landscape.

Marker helps differentiate dormant HIV-infected cells from their health counterpart cells.